Skip to main content
. 2019 Jan 23;7(1):e9291. doi: 10.2196/medinform.9291

Table 2.

Change in the key parameters in the first year of adoption of ThalCare.

Group Pretransfusion Hb (g/dL) Ferritin (ng/mL) Liver size (cm) Spleen size (cm)

Mean (SD) n P value Mean (SD) n P value Mean (SD) n P value Mean (SD) n P value
Quarter 1












Overall 8.0 (1.6) 1009 a 4940 (4628) 427 2.4 (2.4) 869 3.5 (3.8) 863

IGICHb 7.1 (1.4) 151 3856 (3050) 95 3.1 (2.6) 154 3.1 (3.3) 154

SAMc 8.2 (2.0) 232 5376 (2843) 99 3.8 (2.4) 161 5.6 (5.4) 161

TSCSd 8.2 (1.3) 405 3281 (1537) 42 1.2 (1.3) 364 2.4 (2.8) 361

RDTe 7.9 (1.6) 221 3959 (4051) 29 2.9 (2.7) 190 4.1 (3.7) 187

JSCTf 7.5 (1.7) 369 5916 (6380) 162
Quarter 5












Overall 8.3 (1.3) 2891 <.001 3517 (2262) 530 <.001 1.6 (2.0) 2802 <.001 2.2 (3.0) 2798 <.001

IGICH 7.7 (1.4) 214 <.001 2849 (1647) 151 .004 0.9 (1.9) 245 <.001 0.8 (1.9) 245 <.001

SAM 8.7 (1.3) 374 <.001 4569 (2916) 130 .80 3.2 (1.9) 345 .01 2.3 (3.5) 339 <.001

TSCS 8.1 (1.3) 1985 .09 3363 (2039) 88 .80 1.3 (1.7) 1886 .08 2.2 (2.9) 1891 .12

RDT 9.1 (1.3) 318 <.001 3404 (2328) 54 .50 2.4 (2.6) 326 .05 3.4 (3.2) 326 .03

JSCT 9.5 (1.4) 440 <.001 3363 (1785) 107 <.001

aNot applicable.

bIGICH: Indira Gandhi Institute of Child Health.

cSAM: Project Samraksha.

dTSCS: Thalassemia and Sickle Cell Society.

eRDT: Rural Development Trust.

fJSCT: Jai Shivshakti Center for Thalassemia.